Trial intelligence / Profile preview

S-ketamine for early postoperative sleep disturbance after traumatic long-bone fracture surgery

ChiCTR2300072889Phase 4Not yet recruiting

Sponsor
General Hospital of Southern Theater Command of the People's Liberation Army
Start
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine in Postoperative sleep disturbance (PSD) (2 arms), sponsored by General Hospital of Southern Theater Command of the People's Liberation Army. Primary endpoint: Pittsburgh Sleep Quality Index. Planned start Jun 2023; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

Postoperative sleep disturbance (PSD)

Beyond the preview

Go deeper on ChiCTR2300072889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300072889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call